HDDC3 Human

HD domain containing 3 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Key Biochemical Activities

  • ppGpp Hydrolysis: Catalyzes the breakdown of guanosine 3',5'-bis(diphosphate) (ppGpp), a bacterial stringent response alarmone, both in vitro and in vivo .

  • NADPH Phosphatase Activity: Regulates cytosolic NADPH levels, influencing redox homeostasis and ferroptosis .

  • Epigenetic Modulation: Knockdown induces histone deacetylases (HDAC5/9) and represses transcriptional coactivator TAZ via chromatin remodeling .

Biological Pathways

  • Starvation Response: Mediates metabolic adaptation during nutrient deprivation .

  • Cell Proliferation Control: Silencing HDDC3 arrests proliferation in cancer cells (e.g., lung, renal) by downregulating cell cycle genes (CDC6, CDK1) and depleting dNTP pools .

  • Cancer Association: Low HDDC3 expression correlates with better survival in renal cell carcinoma, lung cancer, and follicular lymphoma .

Antitumor Effects

  • Proliferation Arrest: HDDC3 knockdown inhibits tumor sphere formation and xenograft growth in preclinical models .

  • TAZ Repression Mechanism: Reduces H3K27Ac histone marks at TAZ regulatory loci, mediated by HDAC5 upregulation .

  • Drug Sensitivity: HDAC5 inhibitors (e.g., LMK235) reverse TAZ repression, suggesting combinatory therapeutic strategies .

Clinical Correlations

Cancer TypePrognostic AssociationSource
Renal Cell CarcinomaBetter survival with low HDDC3TCGA data
Lung AdenocarcinomaImproved outcomes with reduced levelsGSE62564 dataset
Follicular LymphomaLower expression linked to remissionGSE16131 dataset

Tissue Expression Profile

HDDC3 exhibits broad but variable expression across human tissues:

High Expression TissuesLow Expression Tissues
Cerebral CortexLiver
Hippocampal FormationPancreas
Adrenal GlandBone Marrow

Data from The Human Protein Atlas highlights its presence in neural and endocrine tissues, consistent with its role in stress signaling .

Research Applications

  • Recombinant Protein Use: Employed in studying ppGpp metabolism and bacterial stringent response rescue experiments .

  • Ferroptosis Studies: Serves as a tool to explore NADPH-dependent oxidative stress pathways .

  • CRISPR/Cas9 Models: Used to investigate TAZ-HIPPO signaling crosstalk in cancer .

Product Specs

Introduction
Guanosine-3',5'-bis(diphosphate)-pyrophosphohydrolase MESH1 (HDDC3) is an enzyme that plays a crucial role in bacterial metabolism by regulating the levels of the signaling molecule ppGpp. HDDC3 possesses an active site for ppGpp hydrolysis and a conserved His-Asp-box motif for manganese ion binding, which are essential for its catalytic activity. This enzyme effectively catalyzes the hydrolysis of guanosine 3',5'-diphosphate (ppGpp) both in vitro and in vivo, effectively reducing its cellular concentration. Furthermore, HDDC3 can compensate for the loss of SpoT function, a key enzyme involved in ppGpp synthesis, and mitigate the growth inhibitory effects caused by RelA-mediated ppGpp accumulation in bacteria.
Description
Recombinant human HDDC3, expressed in E. coli, is a purified protein with a molecular weight of 17.9 kDa. It consists of a single polypeptide chain of 160 amino acids, with the first 140 amino acids representing the HDDC3 protein and a 20 amino acid His-tag fused at the N-terminus to facilitate purification. The protein is purified using proprietary chromatographic techniques to ensure high purity.
Physical Appearance
Clear, colorless solution without any visible particles.
Formulation
The HDDC3 protein is supplied in a solution containing 20mM Tris-HCl buffer at pH 8.0, 40% glycerol, 0.15M NaCl, and 1mM DTT. The protein concentration is 0.5mg/ml.
Stability
For short-term storage (up to 4 weeks), keep the HDDC3 vial refrigerated at 4°C. For long-term storage, freeze the vial at -20°C. It is highly recommended to add a carrier protein such as HSA or BSA at a final concentration of 0.1% to prevent protein degradation during long-term storage. Avoid repeated freezing and thawing of the protein solution.
Purity
The purity of HDDC3 is greater than 90% as determined by SDS-PAGE analysis.
Synonyms
Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1, HD domain-containing protein 3, Metazoan SpoT homolog 1, MESH1, Penta-phosphate guanosine-3'-pyrophosphohydrolase, (ppGpp)ase, HDDC3.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSEAAQLLE AADFAARKHR QQRRKDPEGT PYINHPIGVA RILTHEAGIT DIVVLQAALL HDTVEDTDTT LDEVELHFGA QVRRLVEEVT DDKTLPKLER KRLQVEQAPH SSPGAKLVKL ADKLYNLRDL NRCTPEVKIQ.

Q&A

What is HDDC3 and what are its primary functions in human cells?

HDDC3 (HD domain-containing protein 3), also known as MESH1 (Metazoan SpoT homolog 1), functions as a guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase in human cells. The protein contains a specialized active site for ppGpp hydrolysis and a conserved His-Asp-box motif that facilitates Mn(2+) binding, which is critical for its catalytic activity . HDDC3 primarily catalyzes the hydrolysis of guanosine 3',5'-diphosphate (ppGpp) both in vitro and in vivo systems, making it a key enzyme in cellular stress response pathways . Recent research indicates that HDDC3 plays an important role in starvation response mechanisms through its hydrolyzing enzyme activity . Additionally, when studied in bacterial systems, HDDC3 has demonstrated the ability to suppress SpoT-deficient lethality and RelA-induced delayed cell growth, suggesting evolutionary conservation of stress-response mechanisms .

What structural domains characterize HDDC3 and how do they contribute to its function?

HDDC3 is characterized by its HD domain, which contains the catalytic site responsible for its hydrolase activity. The protein's structure includes:

  • An active site specifically configured for ppGpp hydrolysis

  • A conserved His-Asp-box motif essential for Mn(2+) binding

  • A functional domain organization that enables effective catalysis of guanosine 3',5'-diphosphate hydrolysis

The human HDDC3 protein consists of 140 amino acids in its native form, with a molecular mass of approximately 17.9 kDa . The recombinant protein versions often include tags (such as His-tag) at the N-terminus to facilitate purification and experimental manipulation . The protein's structural features are highly conserved across species, with the human version showing 93% sequence identity with both mouse and rat orthologs . This high degree of conservation suggests the critical evolutionary importance of HDDC3's structural elements in maintaining its cellular functions across mammalian species.

How is HDDC3 gene expression regulated in different human tissues?

While comprehensive tissue-specific expression data for human HDDC3 is limited in the provided search results, insights can be drawn from studies of its mouse ortholog and related regulatory elements. In mice, the orthologous gene Hddc3 (Gene ID: 68695) shows tissue-specific expression patterns . Research on LncSync, a long non-coding RNA identified in mouse models, provides insights into potential regulatory mechanisms that may be relevant to human HDDC3 expression.

A recent study demonstrated that Hddc3 is upregulated in LncSync−/− heart tissue as a target of miR-351, suggesting microRNA-mediated regulation . This finding indicates that HDDC3 expression may be controlled through complex RNA-based regulatory networks, potentially including non-coding RNAs and microRNAs. Given the 93% sequence identity between human and mouse HDDC3 proteins , similar regulatory mechanisms might exist in human tissues, though direct evidence would require specific validation studies in human systems.

What are the optimal methods for expressing and purifying recombinant HDDC3 for in vitro studies?

For optimal expression and purification of recombinant HDDC3, the E. coli expression system has been successfully employed in multiple studies. The methodology typically involves:

  • Expression System: E. coli has proven effective for producing non-glycosylated, functionally active HDDC3 .

  • Construct Design:

    • Complete coding sequence (aa 1-140) with an N-terminal His-tag (typically 20 amino acids)

    • Expression vector should contain appropriate promoters for bacterial expression

  • Purification Protocol:

    • Initial capture via Nickel affinity chromatography utilizing the His-tag

    • Further purification through proprietary or conventional chromatographic techniques

    • Buffer optimization: 20mM Tris-HCl buffer (pH8.0), 40% glycerol, 0.15M NaCl, and 1mM DTT has been found effective for maintaining protein stability

  • Quality Control Assessment:

    • SDS-PAGE analysis to confirm purity (>90%)

    • Activity assays to verify functional ppGpp hydrolysis capability

For storage and stability, it's recommended to store the purified protein at 4°C if using within 2-4 weeks, or at -20°C for longer periods. Adding carrier proteins (0.1% HSA or BSA) enhances long-term stability, and multiple freeze-thaw cycles should be avoided .

How should researchers design experiments to evaluate HDDC3's enzymatic activity in vitro?

When designing experiments to evaluate HDDC3's enzymatic activity, researchers should consider the following methodological approach:

  • Substrate Preparation:

    • Prepare ppGpp (guanosine 3',5'-diphosphate) as the primary substrate

    • Consider including control substrates to test specificity

  • Reaction Conditions Optimization:

    • Buffer composition: Tris-HCl (pH 7.5-8.0) with appropriate ionic strength

    • Divalent cations: Include Mn²⁺ (essential for activity due to the His-Asp-box motif)

    • Temperature and pH: Test activity across physiological ranges (30-37°C, pH 6.5-8.5)

  • Activity Measurement Methods:

    • Spectrophotometric assays to measure phosphate release

    • HPLC or mass spectrometry to quantify substrate depletion and product formation

    • Coupled enzyme assays for continuous monitoring of activity

  • Kinetic Parameter Determination:

    • Measure initial reaction rates at varying substrate concentrations

    • Calculate Km, Vmax, and kcat through Michaelis-Menten kinetics analysis

    • Determine enzyme efficiency through kcat/Km ratio

  • Inhibition Studies:

    • Test potential inhibitors to characterize binding site properties

    • Determine inhibition constants and mechanisms (competitive, non-competitive)

For experimental controls, researchers should include heat-inactivated enzyme, substrate-only reactions, and reactions with related enzymes to validate specificity of the observed activity.

What are the recommended approaches for studying HDDC3 in cellular models?

When investigating HDDC3 in cellular models, researchers should consider the following methodological approaches:

  • Cell Line Selection:

    • Choose cell lines relevant to the biological context (cardiac cells for heart-related studies based on LncSync connections)

    • Consider both normal and disease-state cellular models

  • Gene Expression Modulation:

    • Overexpression: Transfect cells with HDDC3 expression vectors

    • Knockdown/Knockout: Use siRNA, shRNA, or CRISPR-Cas9 approaches

    • For miRNA regulation studies, design experiments based on observed miR-351 regulation in mouse models

  • Stress Response Analysis:

    • Given HDDC3's role in starvation response , design nutrient deprivation experiments

    • Implement time-course studies to track HDDC3 expression and activity during stress conditions

  • Detection Methods:

    • Western blotting: For protein expression (use antibodies like PA5-59342 with appropriate blocking controls)

    • qRT-PCR: For transcript analysis

    • Immunofluorescence: For subcellular localization studies

  • Functional Readouts:

    • Measure stress response markers in HDDC3-modulated cells

    • Assess cell viability and growth under various stress conditions

    • Track ppGpp levels using mass spectrometry or specialized assays

When designing controls for these experiments, researchers should include vector-only transfections for overexpression studies, scrambled siRNA for knockdown studies, and wild-type cells subjected to the same stress conditions.

How does HDDC3 interact with the microRNA regulatory network in cardiac pathophysiology?

Recent research has identified intriguing connections between HDDC3 and microRNA-mediated regulation in cardiac tissue. A study examining the long non-coding RNA LncSync revealed that Hddc3 is upregulated in LncSync−/− heart as a target of miR-351 . This finding suggests a complex regulatory network involving HDDC3 in cardiac pathophysiology:

  • miRNA Targeting Mechanism:

    • miR-351 appears to target and regulate HDDC3 expression

    • The dysregulation of this pathway in LncSync knockout models indicates potential roles in cardiac homeostasis

  • Integrated RNA Regulatory Network:

    • LncSync contains sequences encoding the miR-351 cluster (miR-351, miR-503, miR-322) and a target site for miR-181

    • This suggests a multi-layered RNA regulatory network where lncRNAs, miRNAs, and mRNAs (including HDDC3) interact

  • Cardiac-Specific Expression Patterns:

    • LncSync is predominantly expressed in the heart during embryonic development (E9.5-E13.5) and in adult mice

    • This tissue-specific expression pattern suggests specialization of the HDDC3 regulatory network in cardiac function

To investigate these interactions methodologically, researchers should consider:

  • Using cardiac-specific cell lines and primary cardiomyocytes

  • Implementing miRNA mimics and inhibitors to modulate miR-351 levels

  • Performing luciferase reporter assays to confirm direct miRNA-HDDC3 interactions

  • Exploring the effects of HDDC3 modulation on cardiac hypertrophy and homeostasis markers

What is the evolutionary significance of HDDC3's conserved function across species?

HDDC3 demonstrates remarkable evolutionary conservation, suggesting crucial biological functions maintained throughout evolution:

  • Sequence Conservation:

    • Human HDDC3 shares 93% sequence identity with both mouse and rat orthologs

    • This high conservation indicates strong evolutionary pressure to maintain protein structure and function

  • Functional Conservation Across Domains of Life:

    • HDDC3 effectively suppresses SpoT-deficient lethality and RelA-induced delayed cell growth in bacteria

    • This suggests that HDDC3 represents a metazoan homolog of bacterial stress response proteins

  • Conserved Enzymatic Mechanism:

    • The ppGpp hydrolysis capability is maintained from bacteria to mammals

    • The conserved His-Asp-box motif for Mn(2+) binding represents a fundamental catalytic mechanism

To study this evolutionary conservation methodologically, researchers should:

  • Perform comparative biochemical analyses of HDDC3 orthologs from different species

  • Conduct complementation experiments in bacterial systems lacking native ppGpp hydrolases

  • Implement phylogenetic analyses to trace the evolutionary history of HDDC3 and related proteins

  • Investigate whether the regulatory mechanisms (e.g., miRNA regulation) are also conserved across species

How might HDDC3 function be altered in specific disease states or stress conditions?

Given HDDC3's role as a hydrolyzing enzyme involved in starvation response , investigating its function under various disease states and stress conditions is particularly relevant:

  • Cardiac Diseases:

    • The connection to LncSync and cardiac homeostasis suggests HDDC3 may play roles in cardiac hypertrophy and failure

    • Research should focus on HDDC3 expression and activity in models of cardiac stress and disease

  • Metabolic Stress Conditions:

    • As a starvation response enzyme, HDDC3 function may be particularly important during:

      • Nutrient deprivation

      • Hypoxia

      • Oxidative stress

  • Cancer and Proliferative Disorders:

    • Altered stress response mechanisms are hallmarks of cancer

    • HDDC3's role in bacterial growth regulation suggests potential involvement in mammalian cell proliferation control

Methodological approaches to investigate these aspects should include:

  • Tissue and cell samples from relevant disease models and patients

  • Stress induction experiments with careful monitoring of HDDC3 expression and activity

  • Functional studies examining cell survival, growth, and adaptation in HDDC3-modulated systems

  • Correlation analyses between HDDC3 expression/activity and disease progression markers

What control experiments are essential when studying HDDC3 protein interactions?

When investigating HDDC3 protein interactions, researchers should implement the following essential control experiments:

  • Protein-Protein Interaction Controls:

    • Negative Controls:

      • Empty vector/tag-only proteins to control for tag-mediated interactions

      • Structurally similar but functionally distinct HD domain-containing proteins

    • Positive Controls:

      • Known interacting partners from related pathways

      • If studying bacterial homolog interactions, include established SpoT/RelA interactors

  • Antibody Validation Controls:

    • Pre-incubation of antibodies with blocking peptides (e.g., recombinant HDDC3 control fragment)

    • For Western blotting and immunoprecipitation: Use a 100x molar excess of protein fragment control based on concentration and molecular weight

    • Pre-incubate antibody-protein control fragment mixture for 30 minutes at room temperature

  • Functional Validation Controls:

    • Enzymatic activity assays with putative interacting partners

    • Mutational analysis of key residues in the HD domain or His-Asp-box motif

    • Competition assays with excess untagged protein

  • Cellular Localization Controls:

    • Co-staining with established subcellular markers

    • Fractionation controls to verify compartmentalization

    • Exclusion of signal bleed-through in fluorescence microscopy

These controls help distinguish specific HDDC3 interactions from technical artifacts and provide validation for the biological relevance of observed interactions.

How should researchers design experiments to investigate HDDC3's role in stress response pathways?

To effectively investigate HDDC3's role in stress response pathways, researchers should design experiments that systematically analyze its function under various stress conditions:

  • Stress Induction Protocol Design:

    • Nutrient Deprivation: Given HDDC3's role in starvation response , implement:

      • Complete media withdrawal (acute stress)

      • Gradual nutrient depletion (chronic stress)

      • Selective nutrient removal (amino acid, glucose, serum factors)

    • Additional Stressors:

      • Oxidative stress (H₂O₂, paraquat)

      • ER stress (tunicamycin, thapsigargin)

      • Hypoxia (1-5% O₂)

  • Time-Course Experimental Design:

    • Short-term responses (minutes to hours)

    • Long-term adaptation (hours to days)

    • Recovery phase monitoring (stress removal)

  • HDDC3 Manipulation Strategy:

    • Overexpression before stress induction

    • Inducible expression systems to modulate timing

    • Knockdown/knockout before, during, or after stress

  • Readout Selection and Methodology:

    • Molecular Markers:

      • ppGpp levels (primary substrate)

      • Stress response gene expression panel

      • Post-translational modifications of HDDC3

    • Cellular Phenotypes:

      • Survival/death quantification

      • Growth rate measurement

      • Metabolic activity assessment

  • Statistical Analysis Planning:

    • Appropriate sample sizes based on power analysis

    • Time-series analysis for temporal patterns

    • Multivariate analysis for complex phenotypes

These methodological approaches should be tailored to the specific stress response being investigated, with appropriate controls for each experimental condition.

What are the key considerations when designing HDDC3 knockout or knockdown experiments?

When designing HDDC3 knockout or knockdown experiments, researchers should consider several critical factors to ensure reliable and interpretable results:

  • Selection of Genetic Modification Approach:

    • Transient Knockdown:

      • siRNA: For short-term studies (3-5 days)

      • Antisense oligonucleotides: For specific transcript targeting

    • Stable Knockdown/Knockout:

      • shRNA: For long-term expression studies

      • CRISPR-Cas9: For complete gene knockout

      • Conditional systems (Tet-on/off, Cre-loxP): For temporal control

  • Targeting Strategy Optimization:

    • Design multiple targeting sequences to minimize off-target effects

    • Target conserved exons present in all splice variants

    • Avoid regions with high sequence similarity to other HD domain-containing genes

    • For knockouts, consider targeting the His-Asp-box motif region to ensure functional disruption

  • Validation Requirements:

    • Expression Level Verification:

      • qRT-PCR for transcript quantification

      • Western blot for protein depletion (using validated antibodies like PA5-59342)

    • Functional Verification:

      • Enzymatic activity assays (ppGpp hydrolysis)

      • Rescue experiments with wild-type HDDC3 expression

  • Control Implementation:

    • Negative Controls:

      • Non-targeting siRNA/sgRNA sequences

      • Empty vector transfections

    • Specificity Controls:

      • Rescue with RNAi-resistant HDDC3 constructs

      • Parallel targeting of related genes to assess specificity of phenotypes

  • Phenotypic Analysis Considerations:

    • Assess both acute and long-term consequences of HDDC3 depletion

    • Examine cell type-specific effects (especially in cardiac cells)

    • Evaluate responses under both normal and stress conditions

By carefully addressing these considerations, researchers can design robust experiments that reliably determine the specific roles of HDDC3 in various biological contexts while minimizing confounding factors and misinterpretation.

How should researchers interpret conflicting data regarding HDDC3 function across different experimental systems?

When faced with conflicting data regarding HDDC3 function across different experimental systems, researchers should implement a systematic approach to interpretation:

  • System-Specific Context Analysis:

    • Prokaryotic vs. Eukaryotic Systems: HDDC3 suppresses SpoT-deficient lethality in bacteria , but may have distinct functions in mammalian cells

    • Cell Type Variations: Consider tissue-specific roles, particularly in cardiac tissues where HDDC3 regulation by miR-351 has been observed

    • In Vitro vs. In Vivo Discrepancies: Enzymatic activity in purified systems may not fully recapitulate cellular functionality

  • Methodological Evaluation Framework:

    • Protein Form Considerations:

      • Full-length vs. truncated proteins

      • Native vs. tagged versions (His-tagged constructs may affect function)

    • Assay Sensitivity and Specificity:

      • Direct vs. indirect measurements

      • Detection limits and dynamic ranges

    • Experimental Conditions:

      • Buffer composition effects on activity

      • Presence of essential cofactors (Mn²⁺)

  • Reconciliation Strategies:

    • Concentration-Dependent Effects:

      • Test across wide concentration ranges

      • Consider physiological vs. experimental concentrations

    • Temporal Dynamics:

      • Acute vs. chronic effects

      • Time-course analyses to capture transient phenomena

    • Combined Approach Validation:

      • Use multiple orthogonal techniques

      • Validate key findings across different model systems

  • Integrated Data Interpretation:

    • Develop models that accommodate seemingly contradictory results

    • Consider HDDC3's evolutionary context as a metazoan SpoT homolog

    • Evaluate potential bifunctional or context-dependent activities

This structured approach helps researchers distinguish between genuine biological complexity and technical artifacts, leading to more comprehensive understanding of HDDC3 function.

What statistical approaches are most appropriate for analyzing HDDC3 expression data across different tissues or conditions?

When analyzing HDDC3 expression data across different tissues or conditions, researchers should employ statistical approaches that account for biological variability and experimental design:

  • Exploratory Data Analysis:

    • Normalization Methods:

      • Global normalization for cross-tissue comparisons

      • Internal reference genes (housekeeping genes stable across conditions)

      • Spike-in controls for absolute quantification

    • Visualization Techniques:

      • Boxplots for distribution comparison

      • Heatmaps for pattern identification across tissues/conditions

      • Principal Component Analysis (PCA) for multidimensional data reduction

  • Hypothesis Testing Framework:

    • For Two-Group Comparisons:

      • Parametric: t-test (paired/unpaired based on experimental design)

      • Non-parametric: Mann-Whitney U test or Wilcoxon signed-rank test

    • For Multi-Group Comparisons:

      • One-way ANOVA with appropriate post-hoc tests (Tukey, Bonferroni)

      • Kruskal-Wallis with post-hoc Dunn's test for non-parametric data

    • For Time-Course Studies:

      • Repeated measures ANOVA

      • Mixed-effects models for incomplete data

  • Correlation Analysis Approaches:

    • Gene Expression Correlations:

      • Pearson/Spearman correlation with miR-351 levels

      • Correlation with stress response markers

    • Functional Correlation:

      • Expression vs. enzymatic activity

      • Expression vs. phenotypic outcomes

  • Advanced Statistical Methods:

    • Multiple Testing Correction:

      • Benjamini-Hochberg procedure for false discovery rate control

      • Bonferroni correction for family-wise error rate

    • Multivariate Analysis:

      • MANOVA for multiple dependent variables

      • Discriminant analysis for tissue/condition classification

  • Power Analysis Considerations:

    • Calculate minimum sample sizes needed to detect biologically relevant changes

    • Report effect sizes alongside p-values

When implementing these statistical approaches, researchers should clearly report all parameters, assumptions, and limitations to ensure reproducibility and appropriate interpretation of HDDC3 expression data.

What emerging technologies could advance our understanding of HDDC3's molecular functions?

Several cutting-edge technologies show promise for deepening our understanding of HDDC3's molecular functions:

  • Structural Biology Approaches:

    • Cryo-Electron Microscopy (Cryo-EM):

      • Visualize HDDC3 in complex with interaction partners

      • Capture dynamic conformational changes during catalysis

    • AlphaFold2/RoseTTAFold:

      • Predict structural details beyond current experimental data

      • Model interactions with substrates and potential binding partners

  • Single-Cell Technologies:

    • Single-Cell RNA-Seq:

      • Map HDDC3 expression heterogeneity across cell populations

      • Identify cell state-specific regulatory patterns

    • Single-Cell Proteomics:

      • Quantify HDDC3 protein levels at single-cell resolution

      • Correlate with other stress response proteins

  • Advanced Imaging Techniques:

    • Live-Cell HDDC3 Dynamics:

      • CRISPR-based tagging with fluorescent proteins

      • Fluorescence Resonance Energy Transfer (FRET) for interaction studies

    • Super-Resolution Microscopy:

      • Nanoscale visualization of HDDC3 subcellular localization

      • Co-localization with interaction partners at molecular resolution

  • Systems Biology Integration:

    • Multi-Omics Approaches:

      • Integrate transcriptomics, proteomics, and metabolomics data

      • Map HDDC3 within broader stress response networks

    • Network Analysis Tools:

      • Identify hub positions and regulatory relationships

      • Predict functional impacts of HDDC3 modulation

  • Genome Engineering Applications:

    • Base Editors/Prime Editors:

      • Introduce precise mutations in HDDC3 catalytic sites

      • Engineer variants with altered substrate specificity

    • CRISPRi/CRISPRa Systems:

      • Achieve temporal control of HDDC3 expression

      • Establish dose-dependent phenotypic relationships

These emerging technologies, when applied to HDDC3 research, will enable unprecedented insights into its molecular functions, regulatory mechanisms, and potential therapeutic relevance.

What are the most promising therapeutic applications for targeting HDDC3 pathways?

Based on current understanding of HDDC3's functions, several promising therapeutic applications could emerge from targeting its pathways:

  • Cardiac Disease Interventions:

    • Rationale: HDDC3 is regulated by miR-351 in cardiac tissue and may be involved in cardiac homeostasis

    • Potential Approaches:

      • miRNA-based therapies targeting the HDDC3-miR-351 axis

      • Small molecule modulators of HDDC3 enzymatic activity

      • Gene therapy to normalize HDDC3 expression in cardiac pathologies

  • Cellular Stress Response Modulation:

    • Rationale: HDDC3 functions as a hydrolyzing enzyme in starvation response

    • Therapeutic Applications:

      • Enhancing cellular resilience during ischemia/reperfusion

      • Protecting against nutrient deprivation in disease states

      • Targeting stress-induced cellular dysfunction

  • Bacterial Infection Management:

    • Rationale: HDDC3 suppresses SpoT-deficient lethality and RelA-induced delayed cell growth in bacteria

    • Novel Strategies:

      • Disrupting bacterial stress response pathways

      • Adjuvant therapies to enhance antibiotic effectiveness

      • Targeting ppGpp-mediated bacterial persistence

  • Cancer Therapy Approaches:

    • Potential Mechanisms:

      • Exploiting altered stress response pathways in cancer cells

      • Targeting metabolic vulnerabilities through HDDC3 modulation

      • Combination therapies with conventional chemotherapeutics

  • Metabolic Disease Interventions:

    • Theoretical Applications:

      • Modulating cellular adaptations to metabolic stress

      • Targeting tissue-specific stress response pathways

      • Enhancing cellular resilience in metabolic disorders

While these therapeutic directions show promise, several research gaps must be addressed before clinical translation:

  • Establish comprehensive tissue-specific functions of HDDC3

  • Develop selective modulators of HDDC3 activity

  • Validate therapeutic hypotheses in appropriate disease models

  • Determine potential side effects of HDDC3 pathway modulation

How might computational approaches enhance prediction of HDDC3 interactions and functions?

Computational approaches offer powerful tools for predicting and understanding HDDC3 interactions and functions:

  • Structure-Based Prediction Methods:

    • Molecular Docking Simulations:

      • Predict binding of ppGpp and other potential substrates

      • Screen virtual libraries for potential inhibitors or activators

    • Molecular Dynamics Simulations:

      • Model conformational changes during catalytic cycle

      • Predict effects of mutations on HDDC3 structure and function

    • Quantum Mechanics/Molecular Mechanics (QM/MM):

      • Elucidate detailed catalytic mechanisms

      • Model transition states in ppGpp hydrolysis

  • Network-Based Computational Approaches:

    • Protein-Protein Interaction Prediction:

      • Integrate structural data with machine learning algorithms

      • Identify potential binding partners based on interface compatibility

    • Pathway Analysis Tools:

      • Position HDDC3 within stress response networks

      • Predict systemic effects of HDDC3 modulation

  • Evolutionary Computational Methods:

    • Phylogenetic Analysis:

      • Trace evolutionary history across species

      • Identify conserved functional motifs through comparative analysis

    • Coevolution Analysis:

      • Detect co-evolving residues suggesting functional coupling

      • Predict functionally important interaction sites

  • Integrative Multi-Omics Approaches:

    • Data Integration Frameworks:

      • Combine transcriptomic, proteomic, and metabolomic datasets

      • Build predictive models of HDDC3 regulation and function

    • Machine Learning Applications:

      • Predict condition-specific HDDC3 activity

      • Identify biomarkers associated with HDDC3 function

  • Text Mining and Knowledge Extraction:

    • Literature-Based Discovery:

      • Uncover implicit connections between HDDC3 and other biological processes

      • Generate testable hypotheses from existing knowledge

These computational approaches can guide experimental design, prioritize hypotheses for testing, and reveal non-intuitive connections that might otherwise remain undiscovered in HDDC3 research.

Product Science Overview

Gene and Protein Information
  • Gene Symbol: HDDC3
  • Aliases: MESH1, Guanosine-3’,5’-Bis (Diphosphate) 3’-Pyrophosphohydrolase, Metazoan SpoT Homolog 1 (PpGpp)Ase
  • Chromosomal Location: Chromosome 15
  • Protein Function: HDDC3 is a guanosine-3’,5’-bis (diphosphate) 3’-diphosphatase, which means it is involved in the hydrolysis of guanosine pentaphosphate (ppGpp), a molecule that plays a crucial role in the bacterial stringent response to nutrient deprivation .
Biological Role

HDDC3 is involved in the starvation response by hydrolyzing ppGpp, a signaling molecule that accumulates in response to nutrient deprivation and stress conditions. This hydrolysis helps regulate the cellular response to starvation, ensuring survival during adverse conditions .

Expression and Localization

HDDC3 is expressed in various tissues and is localized primarily in the cytosol. It is induced in stressed cells, where it depletes NADPH and stimulates ferroptosis, a type of programmed cell death associated with oxidative stress .

Research and Clinical Significance

Research on HDDC3 has shown its involvement in several physiological and pathological processes:

  • Ferroptosis: HDDC3 plays a role in ferroptosis by depleting NADPH in stressed cells, which can lead to cell death through oxidative stress .
  • Metabolic Regulation: By hydrolyzing ppGpp, HDDC3 helps regulate metabolic processes during nutrient deprivation .
  • Potential Therapeutic Target: Due to its role in stress responses and cell death, HDDC3 is being studied as a potential therapeutic target for diseases related to oxidative stress and metabolic dysregulation .
Experimental Data

Studies using mouse models have provided insights into the function and significance of HDDC3. Knockout mice for the Hddc3 gene have shown various phenotypic changes, including increased levels of circulating alanine and aspartate transaminases, abnormal pancreas and kidney morphology, and enlarged spleen and heart .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.